Plain-English translation of NCT07632352 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing acupuncture as an add-on treatment for people experiencing sudden, severe asthma attacks. Half of the participants will receive standard asthma medications alone, while the other half will receive the same medications plus acupuncture treatment. Researchers want to see if adding acupuncture helps reduce symptoms, improve breathing, and improve quality of life.
Sudden asthma attacks can be frightening and serious, and doctors are always looking for better ways to help patients recover quickly. This trial explores whether acupuncture, combined with proven medications, could offer additional relief during these emergency situations.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either receive standard asthma medications alone or to receive those same medications plus acupuncture treatment. The acupuncture group will receive one 20-minute session per day for 5 consecutive days at specific points on the body. All participants will be monitored for 3 months after treatment with breathing tests, symptom assessments, and blood work to see how well the treatment worked.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
China
Sponsor
Henan University of Traditional Chinese Medicine
Enrollment target
~72 participants
Started
April 2025
Primary completion
September 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Qinmei Yang
Henan University of Traditional Chinese Medicine
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.